Anti-CD45 antibody [PD7/26 + 2B11]
Be the first to review this product! Submit a review
|
(11 Publications)
Mouse Multiclonal CD45 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 11 publications. Immunogen corresponding to Synthetic Peptide within Human PTPRC.
View Alternative Names
CD45, PTPRC, Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, T200, L-CA
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [PD7/26 + 2B11] (AB781)
Formalin fixed paraffin embedded human tonsil tissue, staining CD45 with ab781 in immunohistochemical analysis.
Reactivity data
Product details
This oligoclonal antibody is a cocktail of monoclonal antibodies that have been carefully selected. Oligoclonal antibodies have not only the specificity and batch-to-batch consistency of a monoclonal antibody, but also have the advantage of the sensitivity of a polyclonal antibody due to their ability to recognize multiple epitopes on an antigen.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD45 acts by regulating tyrosine phosphorylation in the immune cell signaling context participating directly in signal transduction. It functions by dephosphorylating specific phosphotyrosine residues on various proteins modulating the signaling threshold required for lymphocyte activation. Although not known to be part of a protein complex CD45 itself shows isoform variation that associates with specific immune cell types impacting their function. Importantly CD45 interacts with multiple signaling molecules to affect cell growth and differentiation.
Pathways
Scientists associate CD45 with signaling pathways such as the T-cell receptor (TCR) and B-cell receptor (BCR) signaling. CD45 modulates the activity of Src family kinases important elements in these pathways making it essential for effective immune response and tolerance. Furthermore interactions between CD45 and proteins like Lck in T-cells or Lyn in B-cells highlight its pivotal role in executing its signaling functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Pulmonary circulation 14:e70024 PubMed39678731
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:7710 PubMed38001067
2023
Applications
Unspecified application
Species
Unspecified reactive species
eNeuro 9: PubMed36635242
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 20:481 PubMed36384529
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 2:100421 PubMed34604819
2021
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 6:3947-3961 PubMed33937594
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of hematology & oncology 10:162 PubMed28985760
2017
Applications
IHC-P
Species
Mouse
Cancer biology & therapy 16:438-49 PubMed25679067
2015
Applications
IHC
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 192:3816-27 PubMed24639355
2014
Applications
Unspecified application
Species
Mouse
Nature medicine 19:421-8 PubMed23475202
2013
Applications
Unspecified application
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com